Vaccine Manufacture and Supply – News and Features

The UK is set to begin a pilot offering eligible patients smaller but equally effective doses of the vaccine used for the UK’s monkeypox outbreak, stretching existing supplies to protect more people.

Technology Networks recently spoke to Drew Buskirk to learn more about peak variation and why it is so important to measure.

Researchers have now developed a special hydrogel that vastly improves the shelf life of vaccines, even without refrigeration.

In this article, we discuss key challenges in vaccine development scale up, highlighting various strategies for overcoming them.

Novel biotechnology platform-based techniques could be more quickly adapted to manufacture vaccines that are more robust, customizable and flexible than traditional approaches.

Researchers set out to find new ways to artificially induce mRNA to respond in ways that could eventually lead to therapeutic outcomes, expanding on the success of the mRNA-based COVID-19 vaccines.

A new study has shown that a single dose of the HPV vaccine has the same efficacy as the current three-dose regimen.

This article will explore how the optimization of cell culture growth medium, the development of superior biological models and the reduced reliance on animal-derived components continue to drive the exciting and rapidly developing art of cell-based vaccine development.

Researchers are rolling out a data set that provides detailed information on COVID-19 vaccine shipments and wastage across the United States, with the goal of spurring new data analysis to improve vaccination efforts in the future.

A survey has been conducted to uncover how the public feels about the distribution of vaccines.